Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy (https://www.myeloma.org/news-events/multiple-myeloma-news/landmark-ecog-acrin-endurance-study-co-authored-international-myeloma-foundation-leaders-provides)